Susan W. Sweeney

Susan Sweeney is Senior Vice President, Global Marketing, Access & Capabilities (GMAC). She is responsible for providing commercial leadership for Amgen products at all stages of the product lifecycle in today’s increasingly dynamic drug access environment. Ms. Sweeney leads a diverse group of teams within GMAC that work to further embed commercial and access requirements early in the development lifecycle with the goal of reducing the total cost of care, improving access to medicines, and enhancing the patient experience. Ms. Sweeney ensures industry-leading commercial and digital capabilities, including “beyond the drug” solutions, are leveraged to maximize value across Amgen’s portfolio for patients, partners, and health systems. Ms. Sweeney came to Amgen from Bristol-Myers Squibb (BMS) in September 2019, where she led commercial activities as President of U.S. Commercial. She joined BMS in 1995 and built a legacy of industry leadership, overseeing the launch and growth of key products within cardiovascular, diabetes, oncology, inflammation, and infectious disease. A history of driving sustained product growth, paired with promoting and advancing diversity as well as mentoring other women in the field, has earned Ms. Sweeney recognition as a leading biopharmaceutical executive. Modern Healthcare named her one of its Top 25 Women Leaders and FiercePharma included her on its list of Fiercest Women in Life Sciences. Ms. Sweeney earned her Master of Public Health degree from Columbia University and a Bachelor of Arts degree from Gettysburg College.